Post-IPO Equity - Arbutus Biopharma - Oct 2, 2017 Funding Round Profile - Cointime

Bitcoin $78,838.39 +3.05%
Ethereum $3,176.59 +4.57%
BNB $631.46 +0.35%
Optimism $1.67 +1.15%
Arbitrum $0.62 +2.73%
Solana $205.72 +2.43%
Polygon $0.40 +3.42%
Cosmos $4.95 +4.32%
Avalanche $31.49 +7.34%

Bitcoin $78,838.39 +3.05%
Ethereum $3,176.59 +4.57%
BNB $631.46 +0.35%
Optimism $1.67 +1.15%
Arbitrum $0.62 +2.73%
Solana $205.72 +2.43%
Polygon $0.40 +3.42%
Cosmos $4.95 +4.32%
Avalanche $31.49 +7.34%

Arbutus Biopharma

company

Funding Round

Post-IPO Equity

Money Raised

$ 116.40M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Roivant Sciences	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Oct 13, 2010	Grant	$ 2.40M	National Institutes of Health	Detail